Ergoteles LLC Bio Techne Corp Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$71.62 - $86.62 $1.15 Million - $1.39 Million	16,102 New	16,102 $1.19 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $510,832 - $708,464	1,808 Added 128.87%	3,211 $912,000
Q2 2022 Aug 12, 2022	BUY	$322.67 - $449.65 $452,706 - $630,858	1,403 New	1,403 $486,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $13.5 Million - $15.5 Million	-29,563 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $13.2 Million - $15.9 Million	29,563 New	29,563 $14.3 Million
Q2 2021 Aug 12, 2021	SELL	$387.35 - $450.26 $11.9 Million - $13.8 Million	-30,606 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$314.62 - $411.0 $5.19 Million - $6.78 Million	16,506 Added 117.06%	30,606 $11.7 Million
Q4 2020 Feb 11, 2021	BUY	$246.9 - $321.87 $3.48 Million - $4.54 Million	14,100 New	14,100 $4.48 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.